R
RadPharm
One of Australia’s leading pharmaceutical manufacturing companies
About RadPharm
Radpharm Scientific, a division of Global Medical Solutions Australia, is a prominent pharmaceutical manufacturing company based in Canberra, ACT. Established in 1986, Radpharm has grown to become a key player in the pharmaceutical industry, serving a diverse range of clients across Australia, Asia, South America, Africa, and the Middle East.
The company specializes in the production and distribution of cold kits, which are essential components used in various medical and diagnostic procedures. These kits are distributed globally, ensuring that healthcare providers have access to high-quality products. Radpharm also offers contract manufacturing services, allowing clients to tailor solutions to their specific requirements. This includes the filling and finishing of both aseptically processed and terminally sterilized liquid and lyophilized (freeze-dried) products.
Radpharm's capabilities extend to the manufacture of sterile vials, which can be empty, liquid-filled, or contain individual sterile components. The company's facility is highly flexible, enabling it to meet the unique needs of its clients. Radpharm holds both TGA (Therapeutic Goods Administration) and APVMA (Australian Pesticides and Veterinary Medicines Authority) licenses, ensuring compliance with stringent regulatory standards.
The business model of Radpharm revolves around providing specialized manufacturing solutions to pharmaceutical companies, healthcare providers, and other entities in the medical field. By leveraging its expertise and state-of-the-art facilities, Radpharm generates revenue through contract manufacturing agreements and the sale of its products to a global client base.
In summary, Radpharm Scientific is a well-established pharmaceutical manufacturer with a strong focus on quality and customization. Its global reach and comprehensive service offerings make it a valuable partner for clients in the medical and healthcare sectors.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1986
- Headquarters
- District of Belconnen, Australia
- Employees
- 28
- Open positions
- None listed
- Dealroom signal
- 41.4/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Image Recognition, Biotechnology
- Technology
- Deep Tech, Recognition Technology
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2007 | $10M | $40M | N47 | — |
| ACQUISITION✓Exit | Sep 2005 | $0 | — | Ampersand Capital Partners | — |
Growth signals
Latest recorded traffic for RadPharm is 250 monthly website visits, up 8.7% over the last three months. RadPharm's team grew 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
N47
Other known investors1 additional known investor
Ampersand Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about RadPharm on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RadPharm’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.